LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data

Photo by airfocus from unsplash

Background Cognitive assessments represent the most common clinical routine for the diagnosis of Alzheimer’s Disease (AD). Given a large number of cognitive assessment tools and time-limited office visits, it is… Click to show full abstract

Background Cognitive assessments represent the most common clinical routine for the diagnosis of Alzheimer’s Disease (AD). Given a large number of cognitive assessment tools and time-limited office visits, it is important to determine a proper set of cognitive tests for different subjects. Most current studies create guidelines of cognitive test selection for a targeted population, but they are not customized for each individual subject. In this manuscript, we develop a machine learning paradigm enabling personalized cognitive assessments prioritization. Method We adapt a newly developed learning-to-rank approach $${\mathtt {PLTR}}$$ PLTR to implement our paradigm. This method learns the latent scoring function that pushes the most effective cognitive assessments onto the top of the prioritization list. We also extend $${\mathtt {PLTR}}$$ PLTR to better separate the most effective cognitive assessments and the less effective ones. Results Our empirical study on the ADNI data shows that the proposed paradigm outperforms the state-of-the-art baselines on identifying and prioritizing individual-specific cognitive biomarkers. We conduct experiments in cross validation and level-out validation settings. In the two settings, our paradigm significantly outperforms the best baselines with improvement as much as 22.1% and 19.7%, respectively, on prioritizing cognitive features. Conclusions The proposed paradigm achieves superior performance on prioritizing cognitive biomarkers. The cognitive biomarkers prioritized on top have great potentials to facilitate personalized diagnosis, disease subtyping, and ultimately precision medicine in AD.

Keywords: pltr; cognitive biomarkers; prioritization; alzheimer disease; disease; cognitive assessments

Journal Title: BMC Medical Informatics and Decision Making
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.